Mixed Dyslipidemia

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

  A clinical trial evaluating bempedoic acid in combination with ezetimibe and either rosuvastatin or atorvastatin in people with primary hype…

• CLINICAL_TRIALS research · 2026-03-30
  Clinical Trial Update: A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

  This clinical trial evaluates bempedoic acid alone or in a fixed-dose single-pill combination with ezetimibe for primary hypercholesterolemi…

• CLINICAL_TRIALS research · 2026-03-20
  Clinical Trial Update: Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  Clinical trial update on treatment with bempedoic acid and its fixed-dose combination with ezetimibe for primary hypercholesterolemia and mi…

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events [Phase 3]

  Phase 3 study evaluating a combination of bempedoic acid, ezetimibe, and a high-intensity statin in patients without cardiovascular events; …

• CLINICAL_TRIALS research · 2026-03-02
  Clinical Trial Update: QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia [Phase 3]

  A Phase 3 clinical trial update for QLC7401 monotherapy in primary hypercholesterolemia or mixed dyslipidemia, sponsored by Qilu Pharmaceuti…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-02-10
  Clinical Trial Update: ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3 [NA]

  The ATLANTIS trial compares phospholipid omega-3 to conventional omega-3 in adults with mixed dyslipidemia. The study status is not yet recr…

• CLINICAL_TRIALS research · 2026-02-03
  Clinical Trial Update: Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

  Novartis is conducting a clinical trial evaluating LDL-C changes and adherence to inclisiran in a population including primary hypercholeste…

• CLINICAL_TRIALS research · 2026-01-13
  Clinical Trial Update: A Study in Patients With Mixed Dyslipidemia [Phase 2]

  This is a Phase 2 clinical trial addressing mixed dyslipidemia that is currently active but not recruiting.

• CLINICAL_TRIALS research · 2025-12-04
  Clinical Trial Update: A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A [Phase 1]

  Phase 1 study to compare pharmacokinetics and safety between AD-117 and AD-117A in mixed dyslipidemia.

• CLINICAL_TRIALS research · 2025-09-12
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

  Recruiting update for a fixed-dose combination of pitavastatin and ezetimibe to evaluate efficacy and safety in primary hypercholesterolemia…

• CLINICAL_TRIALS research · 2025-04-17
  Clinical Trial Update: A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A [Phase 1]

  A Phase 1 trial comparing pharmacokinetics and safety of PA-111 and PA-111A in adults with mixed dyslipidemia, currently recruiting.

• CLINICAL_TRIALS research · 2025-02-05
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-218 [Phase 3]

  A Phase 3 clinical trial evaluating AD-218 for mixed dyslipidemia is currently recruiting. Sponsor: Addpharma Inc.

• CLINICAL_TRIALS research · 2024-09-19
  Clinical Trial Update: Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia [Phase 3]

  A Phase 3 clinical trial is evaluating JS002 as monotherapy for primary hypercholesterolemia and mixed dyslipidemia. The study is currently …